Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2015
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Silvia Stacchiotti, Maria A Pantaleo, Tiziana Negri, et al.
Pediatric Blood & Cancer
|
March 19, 2026
Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features
Alessia Bertolotti, Fabio Bozzi, Elena Conca, et al.
ESMO Open
|
January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
Andrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
Sandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Molecular Cancer Therapeutics
|
October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study
Javier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
JAMA Network Open
|
November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial
Sandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Cancer
|
October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2015
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Silvia Stacchiotti, Maria A Pantaleo, Tiziana Negri, et al.
Pediatric Blood & Cancer
|
March 19, 2026
Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features
Alessia Bertolotti, Fabio Bozzi, Elena Conca, et al.
ESMO Open
|
January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
Andrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
Sandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Molecular Cancer Therapeutics
|
October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study
Javier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
JAMA Network Open
|
November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial
Sandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Cancer
|
October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Page
of 5